A detailed history of Black Rock Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 11,013,932 shares of GH stock, worth $298 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,013,932
Previous 10,831,716 1.68%
Holding current value
$298 Million
Previous $293 Million 22.45%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$17.13 - $26.91 $3.12 Million - $4.9 Million
182,216 Added 1.68%
11,013,932 $227 Million
Q4 2023

Feb 13, 2024

BUY
$21.58 - $29.5 $17.9 Million - $24.5 Million
829,157 Added 8.29%
10,831,716 $293 Million
Q3 2023

Nov 13, 2023

BUY
$25.8 - $39.97 $8.39 Million - $13 Million
325,038 Added 3.36%
10,002,559 $296 Million
Q2 2023

Aug 11, 2023

BUY
$20.94 - $38.01 $79.2 Million - $144 Million
3,782,191 Added 64.16%
9,677,521 $346 Million
Q1 2023

May 12, 2023

BUY
$22.92 - $33.76 $9.16 Million - $13.5 Million
399,865 Added 7.28%
5,895,330 $138 Million
Q4 2022

Feb 13, 2023

BUY
$25.44 - $59.78 $5.78 Million - $13.6 Million
227,304 Added 4.31%
5,495,465 $149 Million
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $2.64 Million - $3.69 Million
60,433 Added 1.16%
5,268,161 $284 Million
Q2 2022

Aug 12, 2022

BUY
$28.82 - $77.35 $3.08 Million - $8.27 Million
106,920 Added 2.1%
5,207,728 $210 Million
Q1 2022

May 12, 2022

SELL
$48.25 - $100.49 $454,611 - $946,816
-9,422 Reduced 0.18%
5,100,808 $338 Million
Q4 2021

Feb 10, 2022

SELL
$88.71 - $120.43 $39.5 Million - $53.7 Million
-445,768 Reduced 8.02%
5,110,230 $511 Million
Q3 2021

Nov 09, 2021

BUY
$98.77 - $132.17 $2.99 Million - $4.01 Million
30,319 Added 0.55%
5,555,998 $695 Million
Q2 2021

Aug 11, 2021

BUY
$109.77 - $165.68 $607 Million - $915 Million
5,525,679 New
5,525,679 $686 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.77B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.